Aggregate Plaque Volume by Coronary Computed Tomography Angiography is Superior and Incremental to Luminal Narrowing for Diagnosis of Ischemic Lesions of Intermediate Stenosis Severity
Overview
Authors
Affiliations
Objectives: This study examined the performance of percent aggregate plaque volume (%APV), which represents cumulative plaque volume as a function of total vessel volume, by coronary computed tomography angiography (CTA) for identification of ischemic lesions of intermediate stenosis severity.
Background: Coronary lesions of intermediate stenosis demonstrate significant rates of ischemia. Coronary CTA enables quantification of luminal narrowing and %APV.
Methods: We identified 58 patients with intermediate lesions (30% to 69% diameter stenosis) who underwent invasive angiography and fractional flow reserve. Coronary CTA measures included diameter stenosis, area stenosis, minimal lumen diameter (MLD), minimal lumen area (MLA) and %APV. %APV was defined as the sum of plaque volume divided by the sum of vessel volume from the ostium to the distal portion of the lesion. Fractional flow reserve ≤ 0.80 was considered diagnostic of lesion-specific ischemia. Area under the receiver operating characteristic curve and net reclassification improvement (NRI) were also evaluated.
Results: Twenty-two of 58 lesions (38%) caused ischemia. Compared with nonischemic lesions, ischemic lesions had smaller MLD (1.3 vs. 1.7 mm, p = 0.01), smaller MLA (2.5 vs. 3.8 mm(2), p = 0.01), and greater %APV (48.9% vs. 39.3%, p < 0.0001). Area under the receiver operating characteristic curve was highest for %APV (0.85) compared with diameter stenosis (0.68), area stenosis (0.66), MLD (0.75), or MLA (0.78). Addition of %APV to other measures showed significant reclassification over diameter stenosis (NRI 0.77, p < 0.001), area stenosis (NRI 0.63, p = 0.002), MLD (NRI 0.62, p = 0.001), and MLA (NRI 0.43, p = 0.01).
Conclusions: Compared with diameter stenosis, area stenosis, MLD, and MLA, %APV by coronary CTA improves identification, discrimination, and reclassification of ischemic lesions of intermediate stenosis severity.
Okan T, Altin C, Topaloglu C, Doruk M, Yilmaz M Diagnostics (Basel). 2025; 15(2).
PMID: 39857090 PMC: 11765540. DOI: 10.3390/diagnostics15020206.
Mochizuki J, Hata Y, Nakaura T, Hashimoto K, Uetani H, Nagayama Y Circ Rep. 2024; 6(12):564-572.
PMID: 39659635 PMC: 11626021. DOI: 10.1253/circrep.CR-24-0086.
Current Status of Cardiac CT for Nuclear Medicine Professionals: Coronary Artery Disease Evaluation.
Ko S Nucl Med Mol Imaging. 2024; 58(7):418-430.
PMID: 39635633 PMC: 11612094. DOI: 10.1007/s13139-024-00859-0.
Hong D, Dai N, Lee S, Shin D, Choi K, Kim S JACC Asia. 2024; 4(10):735-747.
PMID: 39553907 PMC: 11561489. DOI: 10.1016/j.jacasi.2024.06.007.
Computed Tomography Evaluation of Coronary Atherosclerosis: The Road Travelled, and What Lies Ahead.
Ayoub C, Scalia I, Anavekar N, Arsanjani R, Jokerst C, Chow B Diagnostics (Basel). 2024; 14(18).
PMID: 39335775 PMC: 11431535. DOI: 10.3390/diagnostics14182096.